Product Overview
[Drug Name]
Generic Name: Bismuth Potassium Citrate Capsules
Trade Name: Furen Bismuth Potassium Citrate Capsules 0.3g*20s
Pinyin Code: FuRen ZuoZuoSuanZuoJiaJiaoNang 0.3g*20s
[Main Ingredients]
Bismuth potassium citrate, excipients: starch, mannitol, sodium carboxymethyl cellulose, magnesium stearate
[Properties]
This product consists of white granules
[Indications/Main Functions]
For chronic gastritis and relief of stomach pain, heartburn, and acid reflux caused by excessive gastric acid.
[Specifications]
0.3g*20s
[Dosage and Administration]
Oral. Adults: Take one tablet four times daily, with the first three doses half an hour before meals and the fourth dose two hours after dinner. Alternatively, take two tablets twice daily, morning and evening.
[Adverse Reactions]
During treatment, an ammonia odor may occur in the mouth, and the tongue coating and stool may turn grayish-black. This will disappear upon discontinuation. Nausea and constipation may occur occasionally.
[Contraindications]
This product is contraindicated in patients with severe kidney disease and pregnant women.
[Precautions]
1. Do not use this product continuously for more than seven days. If symptoms persist, consult a physician or pharmacist. 2. Consult a physician or pharmacist regarding dosage for children. 3. Do not take other bismuth preparations while taking this product, and high doses should not be taken for long periods of time. 4. In case of overdose or serious adverse reactions, seek medical attention immediately. 5. This product is contraindicated in patients with allergies. Use with caution in those with allergic conditions. 6. Do not use if its properties change. 7. Keep out of reach of children. 8. Children must be supervised by an adult. 9. If you are taking other medications, consult a physician or pharmacist before use.
[Drug Interactions]
Milk and antacids may interfere with the effects of this product and should not be taken simultaneously. 2. Taking this product with tetracycline may affect its absorption. 3. If you are taking other medications, consult a physician or pharmacist before taking this product.
[Pediatric Use]
See [Precautions].
[Elderly Use]
Tolerance in the elderly is similar to that in younger patients.
[Pregnant and Breastfeeding Use]
Contraindicated for pregnant women.
[Overdose]
Unknown.
[Pharmacology and Toxicology]
The main ingredient of this product is bismuth tripotassium dicitrate. It forms a diffuse protective layer on the ulcer surface in the acidic environment of the stomach, preventing the invasion of gastric acid, enzymes, and food. This product also reduces pepsin activity, increases mucin secretion, and promotes the release of prostaglandins from the mucosa, thereby protecting the gastric mucosa. Furthermore, it has a Helicobacter pylori (Hp)-killing effect, thus promoting the healing of gastritis.
[Pharmacokinetics]
It forms an insoluble precipitate in the stomach, with only a small amount of bismuth being absorbed. Bismuth is transported by binding to proteins with a molecular weight of 50,000 or more. Bismuth is primarily distributed in the liver and kidneys and excreted in the urine through the kidneys.
[Storage]
Store in a dry, light-proof, sealed container.
[Packaging]
Aluminum-plastic blister pack, 20 tablets/box
[Expiry Period]
36 months
[Approval Number]
National Medicine Standard No. H20033441
[Manufacturer]
Furen Pharmaceutical Group Co., Ltd.
